Fibromuscular dysplasia of the renal arteries: what do we know in 2024?

Nephrol Ther. 2024 Apr 4;20(2):1-9. doi: 10.1684/ndt.2024.70. Online ahead of print.ABSTRACTFibromuscular dysplasia (FMD) is a rare nonatherosclerotic, noninflammatory vascular disease affecting mostly renal and carotid arteries and is the second most frequent cause of renal artery stenosis. The symptomatology is dominated by arterial hypertension due to the frequent involvement of the renal arteries and depends on the location of the lesions. Most of the cases are middle-aged women of Caucasian origin. There are two subtypes based on angiographic aspect: multifocal FMD (80% of the cases) and focal FMD (rarer with a more balanced sex ratio). Angioplasty of the renal arteries is generally disappointing with less than 50% cure of hypertension. It appears necessary to improve our knowledge of the FMD and to optimize the selection of eligible patients for revascularization with transdisciplinary collegial therapeutic decision.PMID:38567521 | DOI:10.1684/ndt.2024.70
Source: Nephrologie and Therapeutique - Category: Urology & Nephrology Authors: Source Type: research